BioMark’s Quebec Laboratory Begins To Take Shape

biomark diagnostics qtrap 6500 mass spectrometer

BioMark Diagnostics is pleased to announce that the installation of its Quebec laboratory is now underway. With the installation of the Sciex QTrap 6500+ high performance mass spectrometer, BioMark is on target with its plan to build an optimal laboratory infrastructure that will serve as the gold-standard for world-class cancer detection and research. Dr. Jeff […]

BioMark Diagnostics Expands Research Development in Quebec

biomark expands research and development in quebec

Vancouver, British Columbia – (August 13th, 2020) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF), a developer of proprietary, non-invasive, and accurate diagnostic solutions announced today that the Company is moving parts of its lung cancer research and development operations to LE CAMP,  an incubator-accelerator dedicated to tech businesses growth and mentorship. […]

BioMark’s Market Update Report

BioMark Market Update Report

Vancouver, British Columbia – (February 4th, 2020) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) is pleased to provide a market update report with key activities undertaken by BioMark’s team during January 2020. “BioMark is not aware of any negative news that has impacted its share price recently. We continue to execute […]